c, structured programs that intentionally involve just one visit or encounter with a clinic, provider, or program,” which includes digital and self-administered activities ... can experience as a ...
2024 at 5:45 pm CEST – PHAXIAM Therapeutics (Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today provides a business and ...
Optimized cash management, renegotiation of financial obligations and ongoing financial discipline result in 60% reduction in cash outflow compared over the same period in 2023 Cash runway ...
Continuous commitment to create a global leader in phage therapies to treat severe and resistant bacterial infections Ambitious development strategy on track with clear objectives set for the Prosthet ...
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five presentations and one poster across its commercial and development portfolio will be presented ...